| 000 | 01828 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517055427.0 | ||
| 264 | 0 | _c20160815 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-015-0204-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParta, Mark | |
| 245 | 0 | 0 |
_aHaploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cOct 2015 |
||
| 300 |
_a675-80 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aBlood Transfusion, Autologous |
| 650 | 0 | 4 |
_aChimerism _xdrug effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
| 650 | 0 | 4 |
_aGranulomatous Disease, Chronic _xcomplications |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycoses _xetiology |
| 650 | 0 | 4 | _aNational Institutes of Health (U.S.) |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aScedosporium |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aHilligoss, Dianne | |
| 700 | 1 | _aKelly, Corin | |
| 700 | 1 | _aKwatemaa, Nana | |
| 700 | 1 | _aTheobald, Narda | |
| 700 | 1 | _aMalech, Harry | |
| 700 | 1 | _aKang, Elizabeth M | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 35 _gno. 7 _gp. 675-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-015-0204-y _zAvailable from publisher's website |
| 999 |
_c25341090 _d25341090 |
||